Malta Enterprises

Gemcitabine injection is used together with other medicines (eg, carboplatin) to treat patients with advanced ovarian cancer that has come back at least 6 months after treatment with other cancer medicines (platinum-based).

Gemcitabine injection is also used together with other medicines (eg, paclitaxel) to treat metastatic (cancer that has spread) breast cancer in patients who have received other treatments (eg, anthracycline medicine) that did not work well.

It is also used together with other medicines (eg, cisplatin) to treat non-small cell lung cancer that has advanced, spread, or cannot be treated with surgery.

Gemcitabine injection is also used to treat pancreas cancer that has advanced or spread to the other parts of the body in patients who have been previously treated with fluorouracil.

Gemcitabine interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal cells may also be affected by the medicine, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may occur after treatment with gemcitabine has been stopped.

This medicine is to be given only by or under the direct supervision of your doctor.

This product is available in the following dosage forms:

• Solution
• Powder for Solution

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Appropriate studies have not been performed on the relationship of age to the effects of gemcitabine injection in the pediatric population. However, because of this medication's toxicity, it should be used with caution, after less toxic alternatives have been considered or found ineffective. Safety and efficacy have not been established.

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of gemcitabine injection in the elderly. However, elderly women patients are more sensitive to the effects of this medicine than younger adults.

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

• Measles Virus Vaccine, Live
• Mumps Virus Vaccine, Live
• Rotavirus Vaccine, Live
• Rubella Virus Vaccine, Live
• Varicella Virus Vaccine, Live
• Zoster Vaccine, Live

Additional Information:

• Delivery Time: FAST

Lapatinib is used with capecitabine (Xeloda) to treat a certain type of advanced breast cancer in people who have already been treated with other chemotherapy medications. Lapatinib is also used with letrozole (Femara) to treat a certain type of breast cancer in postmenopausal women (women who have experienced a change of life; end of menstrual periods) that has spread to other parts of the body. Lapatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells.

Lapatinib comes as a tablet to take by mouth. It is usually taken once a day, at least 1 hour before or 1 hour after a meal. When lapatinib is used to treat advanced or metastatic breast cancer, it is usually given once daily on days 1 to 21 (along with capecitabine on days 1 to 14) of a 21-day cycle. The cycle may be repeated as recommended by your doctor. When lapatinib is used to treat breast cancer in postmenopausal women, it is usually given once daily along with letrozole. Take all of the lapatinib tablets for your daily dose at one time each day; do not divide the tablets to take as separate doses. Take lapatinib at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take lapatinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the tablets whole; do not split, chew, or crush them.

Your doctor may gradually increase or decrease your dose of lapatinib during your treatment. This depends on how well the medication works for you and any side effects you may experience. Continue to take lapatinib even if you feel well. Do not stop taking lapatinib without talking to your doctor.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Imatinib is used to treat certain types of leukemia (cancer that begins in the white blood cells) and other cancers and disorders of the blood cells. Imatinib is also used to treat certain types of gastrointestinal stromal tumors (GIST; a type of tumor that grows in the walls of the digestive passages and may spread to other parts of the body). Imatinib is also used to treat dermatofibrosarcoma protuberans (a tumor that forms under the top layer of skin) when the tumor cannot be removed surgically, has spread to other parts of the body, or has come back after surgery. Imatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.

Imatinib comes as a tablet to take by mouth. It is usually taken with a meal and a large glass of water once or twice a day. Take imatinib at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take imatinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the tablets whole; do not chew or crush them. If you touch or come into direct contact with a crushed tablet, wash the area thoroughly.

If you are unable to swallow imatinib tablets, you may place all of the tablets that you need for one dose into a glass of water or apple juice. Use 50 milliliters (a little less than 2 ounces) of liquid for each 100-mg tablet and 200 milliliters (a little less than 7 ounces) of liquid for each 400-mg tablet. Stir with a spoon until the tablets crumble completely and drink the mixture immediately.

If your doctor has told you to take 800 mg of imatinib, you should take 2 of the 400-mg tablets. Do not take 8 of the 100-mg tablets. The tablet coating contains iron, and you will receive too much iron if you take 8 of the 100-mg tablets.

Your doctor may increase or decrease your dose of imatinib during your treatment. This depends on how well the medication works for you and on the side effects you experience. Talk to your doctor about how you are feeling during your treatment. Continue to take imatinib even if you feel well. Do not stop taking imatinib without talking to your doctor.

Additional Information:

• Delivery Time: FAST

Additional Information:

• Packaging Details: 1*60 TABLETS IN A BOTTLE BY EMCURE.

Additional Information:

• Packaging Details: 1*10 TABLETS BY CUREMART PHARMA PVT LTD

Additional Information:

• Packaging Details: ZELGOR 500MG ABIRATERONE ACEATET TABLETS 500MG 60 TABLETS IN A BOTTLE

• Treatment of Acne
• Acute promyelocytic leukaemia

• Headache
• Fever
• Bone pain
• Rash
• Visual impairment
• Hair loss
• Increased sweating
• Mucosal inflammation
• Erythema (skin redness)
• Skin irritation
• Dry skin
• Dry lips
• Pale red skin
• Increased sensitivity to light

Additional Information:

• Delivery Time: FAST

Additional Information:

• Packaging Details: Manufactured By Hetero Healthcare Limited. (Imatero 400mg Tablet).

Enzyl 160mg Tablet should be taken with or without food, preferably at a fixed time every day. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Enzalutasun 40mg Capsule contains the active ingredient enzalutamide. It is an antineoplastic drug that belongs to the category of medicines known as androgen receptor inhibitors. This medication is used in the treatment of advanced prostate cancer in patients who do not respond to surgical or hormonal treatments. 

It is not recommended to take Enzalutasun 40mg Capsule if you are allergic to enzalutamide or any of its ingredients. During this treatment, your doctor may periodically monitor for Prostate-specific antigen (PSA) tests. This blood test measures the level of PSA, a protein produced by the prostate gland that can be elevated in men with prostate cancer. PSA levels can help monitor the progression of the disease and the response to treatment. Other tests also include liver function tests and complete blood count(CBC) to prevent serious complications

• Skin and Soft tissue infectionsSkin and soft tissue infections (SSTI) are bacterial infections of the skin, muscles, and connective tissue such as ligaments and tendons. Targocid 400 mg Injection is used in the treatment of skin and soft tissue infection.
• PneumoniaPneumonia is a form of acute respiratory infection that affects the lungs. In this condition, the air sacs are filled with pus and fluid causing breathing difficulty, coughing, chest pain, etc. Targocid 400 mg Injection is used in the treatment of pneumonia.
• Urinary Tract InfectionUrinary Tract Infection is an infection in any part of the urinary system, the kidneys, bladder or urethra. Targocid 400 mg Injection used in the treatment of severe urinary tract infection.
• Bone and Joint infectionsTargocid 400 mg Injection is used in the treatment of bone and joint infections such as osteomyelitis and infectious arthritis caused by gram-positive bacteria.
• Bacterial endocarditisBacterial endocarditis is an infection of the inner lining of the heart, that is caused by gram-positive bacteria. Targocid 400 mg Injection is used in the treatment of endocarditis.